REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 03, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged violations of federal securities laws. This could lead to potential financial liabilities and impact investor confidence.
The announcement of a class action lawsuit against Regeneron Pharmaceuticals is likely to negatively impact its stock price in the short term. Legal issues can lead to financial liabilities and damage investor confidence, causing potential sell-offs.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100